Clinical Trials Browser

Phase 2/3 × Stomach Neoplasms × tislelizumab × Clear all

NCT05325528 2023-02-01

Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms